This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...

This includes a study to evaluate LockeT in patients that require large-bore venous access such as those used with the Micra pacemakers from Medtronic, the Watchman devices from Boston Scientific, and ...

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, "Orchestra BioMed" or the "Company"), a biomedical innovation company accelerating high-impact technologies ...

NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact ...

With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

SCSU’s MedTech programs give students more than a degree — they open doors to an exciting field that has the power to change ...

Boston Scientific faces intense competition from J&J, Medtronic, and Abbott Laboratories ... And with surging demand for two ...

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

The Global Surgical Stapling Device Market is projected to be valued at US$ 3,977.40 million in 2023, with an anticipated growth trajectory reaching US$ 5,930.60 million by 2033. The market is ...

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

The Twin Cities metro is home to some of the strongest and largest medical technology and device companies in the nation, ...